MODELS FOR REIMBURSEMENT FOR ONCOLOGY PRODUCTS IN LATIN AMERICAN COUNTRIES:
THE PERSPECTIVE OF BRAZIL, COLOMBIA, AND MEXICO

Thursday, 10 September 2009
18:15 – 19:15

Sponsored by Pfizer

This symposium is free and open to all ISPOR delegates, no pre-registration required.

The learning objectives for this symposium are to: understand the reimbursement models for oncology products in Brazil, Colombia, and Mexico; share experiences and challenges related to obtaining reimbursement for life-threatening diseases in these countries; and discuss what health policies should be implemented in order to maximize oncology patient’s outcomes.

Moderator:
Iris Contreras-Hernández MD, MSc, Health Economics Researcher, Social Security Mexican Institute (IMSS), Mexico City, Mexico 

Speakers:
José Getulio Martins Segalla, MD, President of the Brazilian Society of Clinical Oncology (Sociedade Brasileira de Oncologia Clínica)/ Chief of Clinical Oncology Department and Research Director from Hospital Amaral Carvalho, Brazilian Society of Clinical Oncology, Jaú, Brazil

Nelson Alvis, MD, PhD, Health Economics, Professor and Health Economics Researcher, Universidad de Cartagena – Health Technology Assessment Department, Cartagena, Colombia

Iris Contreras-Hernández MD, MSc, Health Economics Researcher, Social Security Mexican Institute (IMSS), Mexico City, Mexico